ALBUTEROL SULFATE solution

দেশ: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

Albuterol Sulfate (UNII: 021SEF3731) (Albuterol - UNII:QF8SVZ843E)

থেকে পাওয়া:

Holopack International

INN (আন্তর্জাতিক নাম):

Albuterol Sulfate

ফার্মাসিউটিকাল ফর্ম:

SOLUTION

রচনা:

0.83 mg in 1 mL

প্রশাসন রুট:

RESPIRATORY (INHALATION)

প্রেসক্রিপশন টাইপ:

PRESCRIPTION DRUG

থেরাপিউটিক ইঙ্গিত:

Albuterol Sulfate Inhalation Solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. Albuterol Sulfate Inhalation Solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. Albuterol Sulfate Inhalation Solution, 0.083%* *Potency expressed as albuterol. Read complete instructions carefully before using. 1. Twist open the top of one Albuterol Sulfate Inhalation Solution unit-of-use container and squeeze the entire contents into the nebulizer reservoir (Figure 1). 2. Connect the nebulizer reservoir to the mouthpiece or face mask (Figure 2). 3. Connect the nebulizer to the compressor. 4. Sit in a comfortable, upright position; place the mouthpiece in your mouth (Figure 3)(or put on the face mask); and turn on the compressor. 5. Breathe as calmly, deeply and evenly as possible until no more mist is formed in the nebulizer chamber (about 5 to 15 minut

পণ্য সারাংশ:

Albuterol Sulfate Inhalation Solution, 0.083% is contained in plastic sterile unit dose vials of 3 mL each, supplied in foil pouches: NDC carton of 25 vials NDC carton of 30 vials NDC carton of 60 vials Protect from light. Store between 2° and 25° C (36° and 77° F). Discard if solution becomes discolored. (Note: Albuterol Sulfate Inhalation Solution is a clear, colorless to light yellow solution.) KEEP OUT OF REACH OF CHILDREN Manufactured By: Holopack International Columbia, SC 29203

পণ্য বৈশিষ্ট্য

ALBUTEROL SULFATE- ALBUTEROL SULFATE SOLUTION
HOLOPACK INTERNATIONAL
----------
ALBUTEROL SULFATE INHALATION SOLUTION, 0.083%*
*POTENCY EXPRESSED AS ALBUTEROL.
RX ONLY
FOR ORAL INHALATION ONLY
DESCRIPTION
Albuterol Sulfate Inhalation Solution is a relatively selective
beta2-adrenergic bronchodilator (see
CLINICAL PHARMACOLOGY). Albuterol sulfate, USP, the racemic form of
albuterol, has the
chemical name α
-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-α,α'-diol sulfate
(2:1) (salt) and the
following structural formula:
Albuterol sulfate has a molecular weight of 576.71, and the molecular
formula is (C
H NO ) •
H SO . Albuterol sulfate is a white crystalline powder, soluble in
water and slightly soluble in ethanol.
The World Health Organization recommended name for albuterol base is
salbutamol.
Albuterol Sulfate Inhalation Solution requires no dilution before
administration by nebulization.
Each milliliter of Albuterol Sulfate Inhalation Solution contains 0.83
mg of albuterol (as 1 mg of
albuterol sulfate) in an isotonic, sterile, aqueous solution
containing sodium chloride; sulfuric acid is
used to adjust the pH to between 3 and 5. Albuterol Sulfate Inhalation
Solution contains no sulfiting
agents or preservatives.
Albuterol Sulfate Inhalation Solution is a clear, colorless to light
yellow solution.
CLINICAL PHARMACOLOGY
_In vitro_ studies and in vivo pharmacologic studies have demonstrated
that albuterol has a preferential
effect on beta -adrenergic receptors compared with isoproterenol.
While it is recognized that beta -
adrenergic receptors are the predominant receptors in bronchial smooth
muscle, data indicate that 10%
to 50% of the beta-receptors in the human heart may be beta
-receptors. The precise function of these
receptors has not been established.
The pharmacologic effects of beta-adrenergic agonist drugs, including
albuterol, are at least in part
attributable to stimulation through beta-adrenergic receptors of
intracellular adenyl cyclase, the enzyme
that catalyzes the conversion of adenosine trip